Annual income statement for Nulab, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,328 | 2,706 | 3,663 | 4,112 | 4,394 |
| Cost of Revenue | |||||
| Gross Profit | 1,416 | 1,734 | 2,638 | 2,964 | 3,243 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,161 | 2,611 | 3,338 | 3,464 | 4,151 |
| Operating Profit | 167 | 94.9 | 325 | 648 | 243 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 164 | 86.3 | 323 | 650 | 263 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 198 | 88.4 | 308 | 553 | 179 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 198 | 88.4 | 308 | 553 | 179 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 198 | 88.4 | 308 | 553 | 179 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 30.7 | 14.6 | 48.2 | 83.9 | 39.4 |
| Dividends per Share |